Therefore, we selected ALKBH5 as the main regulator of LINC00968 m6A modification involved in RA disease activity and immune-inflammatory responses, suggesting LINC00968 as a potential m6A target of ALKBH5. The gene discussed is ALKBH5; the disease is rheumatoid arthritis.